Magnitude Biosciences provides an in-vivo drug discovery platform using C. elegans to help researchers accelerate aging and disease research. The company is based at Durham University and NETPark in County Durham, serving the pharmaceutical and biotechnology sectors.
Subscribe to see Magnitude Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Magnitude Biosciences is a healthcare company headquartered in United Kingdom, founded in 2018. Its most recent funding round raised $1.6M in September 2026. Xcout tracks 1 named person at Magnitude Biosciences, including Dr. Fozia Saleem (CEO).
As of 20 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $1.6M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Magnitude Biosciences's closest competitors — see the full list of competitors and alternatives →
InSphero provides 3D in vitro cell culture models, microplates, organ-on-a-chip platforms, and related services for drug discovery and safety testing. The company serves pharmaceutical, biotechnology, and research organizations seeking non-animal testing alternatives to evaluate drug efficacy, liver safety, oncology, and other complex diseases.
Danu Insights Ltd provides an AI-driven platform designed to optimize experiments for the life sciences sector, serving industries ranging from biotechnology to clinical research. The company's technology aims to help organizations improve experiment outcomes and accelerate research and development.
INDIGO Biosciences, Inc. provides life science solutions, specializing in in vitro cell-based reporter assay systems and screening services for pharmaceutical and research markets. Headquartered in State College, Pennsylvania, the company supports environmental, toxicological, and drug discovery testing.
Aurora Bio, Inc. provides life science research products and services, including fluorescence assay kits, recombinant proteins, inhibitor compounds, and protein purification resins. It also offers custom services such as assay development, high-throughput compound library screening, protein expression, and antibody conjugation primarily for researchers in drug discovery.
Axol Bioscience is a leading provider of iPSC-derived cells and related services, supporting neuroscience, ophthalmology, and cardiotoxicity drug discovery with advanced human disease models.
Biocytogen is a biotechnology research company headquartered in Beijing, China, with major international branches in the United States and Germany. The company specializes in developing novel antibody discovery platforms and gene-edited animal models for drug development.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Magnitude Biosciences? Suggest a correction · Work at Magnitude Biosciences? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.